跳至主要内容
临床试验/CTRI/2023/10/058242
CTRI/2023/10/058242尚未招募2/3 期

A comparative clinical study of Gokshuradi Guggulu and Renogrit in Chronic Kidney Disease

Patanjali Bhartiya Ayurvigyan Evum Anusandhan Sansthan1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年10月13日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
subejctive criteria-

研究概览

简要总结

This is an open label double arm comparative clinical study , comparing the efficacy of Gokshuradi Guggulu 500 mg 2 Tablets twice daily before meals and Renogrit tablet 540 mg each 2 tablets twice daily before meals for 18 months in 40 patients of Chronic Kidney Disease that will be conducted in OPD no. 13/14 at Patanjali Ayurveda hospital, Haridwar

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
16.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • .Clinically stable patients of stage 1, 2 as per K/DOQI guidelines 2.Creatinine level i.e., between 1.5 mg/dl to 5 mg/dl.
  • 3.Blood urea levels between- 50 to 130 mg/dl 4.Patients of either gender between the age group of 16 to 70 years of age.

排除标准

  • 1.Associated complications like respiratory distress, Anuria, oliguria, cardiovascular complications.
  • 2.Patients Requiring dialysis and renal transplant.
  • 3.Patients with Malignant hypertension, Uncontrolled Diabetic patients, SLE.
  • Pregnant, lactating Women.

结局指标

主要结局

subejctive criteria-

时间窗: 0 day 30th day 60th day

2.nausea

时间窗: 0 day 30th day 60th day

1.pedal edema

时间窗: 0 day 30th day 60th day

3.anorexia

时间窗: 0 day 30th day 60th day

4.vomiting

时间窗: 0 day 30th day 60th day

5.Breathlessness

时间窗: 0 day 30th day 60th day

6.tiredness

时间窗: 0 day 30th day 60th day

次要结局

  • Objective criteria(1 Hb)

研究者

发起方
Patanjali Bhartiya Ayurvigyan Evum Anusandhan Sansthan
申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验